Market Overview

Benzinga's Top Upgrades

Related ABT
Abbott Laboratories Conference Call Highlights
UPDATE: Abbott Q3 Earnings Top Street View
Making Money With Charles Payne: 10/17/14 (Fox Business)
Related PCLN
Credit Suisse Lowers Price Target For Priceline Group Amid FX Headwinds
How To Use S&P 500 Futures To Predict Market Movement
Tech M&A Surges in 2Q (Fox Business)

Analysts at Goldman Sachs upgraded Abbott Laboratories (NYSE: ABT) from “neutral” to “buy.” The target price for Abbott Laboratories has been raised from $38 to $44. Abbott's stock closed at $36.59 on Friday.

Deutsche Bank upgraded priceline.com (NASDAQ: PCLN) from “hold” to “buy.” The target price for priceline.com has been raised from $715 to $900. priceline.com's shares closed at $813.66 on Friday.

Analysts at Maxim Group upgraded J.C. Penney Company (NYSE: JCP) from “hold” to “buy.” The target price for J.C. Penney has been raised from $16.50 to $27. J.C. Penney's shares closed at $18.01 on Friday.

Morgan Stanley upgraded E-Commerce China Dangdang (NYSE: DANG) from “equal-weight” to “overweight.” The target price for E-Commerce China Dangdang has been raised from $5 to $6.50. E-Commerce China Dangdang's shares closed at $5.71 on Friday.

Latest Ratings for ABT

DateFirmActionFromTo
Jul 2014BarclaysMaintainsEqual-weight
Jul 2014Raymond JamesMaintainsOutperform
Jul 2014JefferiesMaintainsBuy

View More Analyst Ratings for ABT
View the Latest Analyst Ratings

Posted-In: top upgradesUpgrades Analyst Ratings

 

Related Articles (ABT + DANG)

Around the Web, We're Loving...

Get Benzinga's Newsletters